Sarai Louise Hinkley, LMHC, R-DMT in Adamant, VT - Counselor

Sarai Louise Hinkley, LMHC, R-DMT is a Counselor - Mental Health based in Adamant, Vermont. Sarai Louise Hinkley is licensed to practice in Massachusetts (license number 10821) and her current practice location is 412 Adamant Rd, Adamant, Vermont. She can be reached at her office (for appointments etc.) via phone at (339) 235-0203.

NPI number for Sarai Louise Hinkley is 1417576919 and her current mailing address is Po Box 7, Adamant, Vermont. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1417576919.

Contact Information

	Sarai Louise Hinkley, LMHC, R-DMT
	412 Adamant Rd, Adamant, VT 05640
	(339) 235-0203
	Not Available

Healthcare Provider's Profile

Full Name	Sarai Louise Hinkley
Gender	Female
Speciality	Counselor - Mental Health
Location	412 Adamant Rd, Adamant, Vermont
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1417576919
Provider Enumeration Date: 04/14/2020
Last Update Date: 04/14/2020

Medical Identifiers

Medical identifiers for Sarai Louise Hinkley such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1417576919	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
101YM0800X	Counselor - Mental Health	10821 (Massachusetts)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Sarai Louise Hinkley is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Sarai Louise Hinkley, LMHC, R-DMT Po Box 7, Adamant, VT 05640-0007 Ph: (339) 235-0203	Sarai Louise Hinkley, LMHC, R-DMT 412 Adamant Rd, Adamant, VT 05640 Ph: (339) 235-0203

News Archive

Pros and cons of HIV treatments in developing countries

Palumbo is co-leading a clinical study of anti-HIV medicines in Africa and India for the International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT). The randomized trial found that a cohort of 82 HIV-infected children ages 6 to 35 months responded better to treatment with the protease-inhibiting drug lopinavir (LPV/r) than did a cohort of 82 children in the same age group who received the anti-retroviral drug nevirapine (NVP).

Study uses computational modeling of coronavirus spike proteins to examine dynamics responsible for immunogenicity and immune escape

A new study published on the bioRxiv* preprint server focused on the development of dynamic computational models for a large subset of S proteins of SARS-CoV, MERS-CoV, and SARS-CoV-2.

E-QURE inks distribution agreement with Rubifarm S.A.

E-QURE Corp. (OTCQB: EQUR), a Delaware Corporate engaged in the commercialization of its Bio-electrical Signal Therapy device ("BST Device"), a new and novel electrotherapy for the noninvasive treatment of hard to heal chronic wounds, today announced that the Company has signed its first distribution agreement with Rubifarm S.A., an Argentinian distributor specializing in medical devices, and. The agreement goes into effect immediately.

Coalition calls for affordable and flexible essential health benefits package

The newly-formed Essential Health Benefits Coalition today urged the Department of Health and Human Services (HHS) to hold the cost and affordability of the essential health benefits package paramount as recommended by the Institute of Medicine (IOM).

Sarai Louise Hinkley, LMHC, R-DMT - Counselor in Adamant, VT